Abiopharma

🔍 Ballhaus William L (Director)

Company: MERCURY SYSTEMS INC (MRCY)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 153,676 shares of Common Stock at $43.0 per share (Direct)
  Date: 2026-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 453,512.33 | transaction_form_type: 4 | Footnotes: F1
• Sold 107,628 shares of Common Stock at $87.089 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 345,884.33 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 3,448 shares of Common Stock at $87.993 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 342,436.33 | transaction_form_type: 4 | Footnotes: F2, F4
• Acquired 68,476 shares of Common Stock at $43.0 per share (Direct)
  Date: 2026-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 410,912.33 | transaction_form_type: 4 | Footnotes: F1
• Sold 38,276 shares of Common Stock at $88.913 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 372,636.33 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 10,814 shares of Common Stock at $89.744 per share (Direct)
  Date: 2026-08-26 | Code: S | equity_swap_involved: 0 | shares_owned_after: 361,822.33 | transaction_form_type: 4 | Footnotes: F2, F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: 401K Plan | shares_owned_after: 1,403.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: By Milestone Road Holdings, LLC | shares_owned_after: 7,066.17
• Sold 153,676 shares of Employee Stock Option (Right to Buy) at $43.0 per share (Derivative)
  Date: 2026-08-25 | Code: M | Expires: 2027-08-17 | Exercise: 2026-08-17 | equity_swap_involved: 0 | shares_owned_after: 68,476.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 68,476 shares of Employee Stock Option (Right to Buy) at $43.0 per share (Derivative)
  Date: 2026-08-26 | Code: M | Expires: 2027-08-17 | Exercise: 2026-08-17 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the exercise of a stock option award scheduled to expire on August 17, 2027.
• F2: Represents the sale of shares intended solely to cover the exercise price, applicable withholding taxes and related transaction costs of stock options exercised on the same date.
• F3: This transaction was executed in multiple trades at prices ranging from $86.800 to $87.800. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $87.820 to $88.325. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $88.500 to $89.435. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $89.560 to $89.960. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.